Abstract
Background
The suicide risk was higher in kidney cancer patients than in the general population. The purpose of this study was to characterize the suicide rates among kidney cancer patients and to identify the potential risk factors associated with suicide from the Surveillance, Epidemiology, and End Results (SEER) database.
Methods
Kidney cancer patients were identified from the SEER database during 1973‐2015. Suicide rates and standardized mortality ratios (SMRs) of this population were calculated, and the US general population during 1981‐2015 was chosen as a reference. Univariable and multivariable Cox regression were performed to find out potential risk factors of suicide.
Results
There were 207 suicides identified among 171 819 individuals with kidney cancer observed for 948 272 person‐years. The suicide rate was 21.83 per 100 000 person‐years, and SMR was 1.83 (95% CI: 1.59‐2.10). On Cox regression, diagnosis in early years (1973‐1982 vs 2003‐2015, HR: 2.03, 95% CI: 1.01‐4.11, P = 0.048; 1983‐1992 vs 2003‐2015, HR: 1.99, 95% CI: 1.18‐3.35, P = 0.010), male sex (vs female sex, HR: 4.43, 95% CI: 2.95‐6.65, P < 0.001), unmarried status (vs married status, HR: 2.54, 95% CI: 1.91‐3.38, P < 0.001), non‐black race (white race vs black race, HR: 4.47, 95% CI: 2.09‐9.58, P < 0.001; other races vs black race, HR: 3.01, 95% CI: 1.08‐8.37, P = 0.035), higher histologic grade (grade IV vs grade I, HR: 3.27, 95% CI: 1.50‐7.13, P = 0.003; grade III vs grade I, HR: 2.13, 95% CI: 1.19‐3.81, P = 0.011) and cancer‐directed surgery not performed (vs performed, HR: 2.78, 95% CI: 1.52‐5.11, P < 0.001) were independent risk factors of suicide among kidney cancer patients.
Conclusions
Diagnosis in early years, male sex, unmarried status, non‐black race, higher histologic grade, and cancer‐directed surgery not performed were significantly associated with suicide among kidney cancer patients. In order to prevent suicidal death, clinicians should pay more attention to patients with high‐risk factors of suicide.
Keywords: kidney cancer, risk factors, SEER, suicide
1. BACKGROUND
Suicide, a global public health problem, was a complex behavior affecting by physiological, psychological, social, environmental, and cultural factors.1 World Health Organization reported that over 800 000 persons committed suicide every year and one person every 40 seconds.1 Globally, 81 7000 persons died of suicide in 2016, comprising 1.49% of total deaths.2 In the US, the suicide mortality rate was 15.3 per 100 000 in 2016, which was relatively higher in comparison with the surrounding countries.3
In recent years, studies reported a notable association between depression and suicide, and the ssuicide rate among patients with depression was much higher than the usual population.4, 5, 6 The patients diagnosed as diseases with poor prognosis, especially cancer, were more likely to feel hopeless, suffer from depression and subsequently commit suicide.7, 8 Several studies reported increased suicide ideation and attempts in patients with cancer and showed a high suicide rate among these patients.7, 9, 10 Compared with the general population, the suicide rate of patients with cancer was almost twice in the US.11 A current study by Zaorsky et al revealed that the cancer patients had a suicide SMR of 4.44 in comparison with the general population.12 For the behavior of suicide could be potentially recognized and prevented, the identification of patients with high‐risk factors of suicide was particularly important. The risk factors including male sex, white race, and unmarried status were demonstrated to be associated with a high incidence of suicide for some types of cancer, such as breast cancer, colorectal cancer, and pancreatic cancer.13, 14, 15
Kidney cancer was the seventh and the ninth most common malignancy in men and women.16 In the US, the number of patients with kidney cancer was estimated to be 65 340 in 2018, and the number of death cases was estimated to be 14 970.17 Misono et al reported increased suicide rates of patients with cancer in the US and characterized this specific population.11 However, the risk factors of suicide in patients with kidney cancer were not involved in the study. Klaassen et al selected the patients with kidney cancer through the SEER database and identified the risk factors of suicide.18 However, papillary renal cell carcinoma was not included in this study, which was the second most frequency subtype in all renal cortical neoplasms.19 Histologic subtype was an important prognostic factor for kidney cancer survival.20 To our best knowledge, there was no previous study to investigate the association between histologic subtype and suicide among patients with kidney cancer. Additionally, few studies explored the risk factors associated with suicide among kidney cancer patients based on a large representative sample. Therefore, the purpose of our study was to characterize the suicide rates and SMRs in this specific cohort and to identify the potential risk factors relevant to suicide based on the SEER database.
2. METHODS
2.1. Data source
All patients with kidney cancer were selected from the SEER database (1973‐2015). The SEER database reported cancer‐specific outcomes from specific geographic areas covering 28% of the US population. The data in the SEER program were considered to be representative of the entire US population.21 The SEER database could freely provide information including patient demographics, cancer incidence, and survival data to registered researchers. The permission of accessing the database was obtained after we signed and submitted a SEER Research Data Agreement form through e‐mail. The software of SEER*Stat (version 8.3.5) was used to identify the patients.
2.2. Study population
Patients were identified using the primary site codes (C64.9 and C65.9) for kidney and morphology codes (8050/3, 8260/3, 8310/3, 8312/3, 8313/3, 8316/3, 8317/3, 8318/3, and 8319/3) based on International Classification of Diseases for Oncology codes (3rd edition) for kidney cancer.
2.3. Measurements of variables
Demographic and clinical variables of interest were collected through the software of SEER*Stat, including year of diagnosis (1973‐1982, 1983‐1992, 1993‐2002, 2003‐2015), age at diagnosis (≤39, 40‐49, 50‐59, 60‐69, 70‐79, ≥80), gender (male, female), marital status (married, unmarried), race (black, white, others), SEER histologic stage (localized, regional, distant), histologic grade (well differentiated; grade I, moderately differentiated; grade II, poorly differentiated; grade III, undifferentiated; anaplastic; grade IV), histologic subtype (clear renal cell carcinoma, papillary renal cell carcinoma, chromophobe renal cell carcinoma, sarcomatoid renal cell carcinoma, collecting duct renal cell carcinoma, others), survival time, vital status, surgery (yes, no), and radiotherapy (yes, no). Based on marital status, the patients were classified as married and unmarried, and the unmarried status included single, widowed, divorced/separated, and unmarried or domestic partner. The exclusion criteria included patients with unknown age, unknown follow‐up, and all autopsy or death certificate cases. The steps of patient selection were exhibited in Figure 1.
Figure 1.
The flow diagram of patient selection
2.4. Ascertainment of the outcome
The primary outcome of this study was suicidal death, which was ascertained by cause of death code (suicide and self‐inflicted injury) in the software of SEER*Stat.
2.5. Statistical analysis
The suicide rates between groups were compared with the chi‐square test, and the Bonferroni‐corrected P‐value was used for multiple comparisons. SMR was calculated using the ratio of actual mortality with expected mortality. Because of the lack of suicide rates during 1973‐1980 in the Centers for Disease Control and Prevention's Web‐based Injury Statistics Query and Reporting System, the US general population between 1981 and 2015 was chosen as a reference, and a sensitive analysis with the kidney cancer patients diagnosed in 1981‐2015 was performed to validate the robustness of SMRs. Ninety‐five percent of CI of SMR was obtained through the method of Byar's approximation.22 Univariable and multivariable Cox regression were performed to generate crude and adjusted HRs and 95% CI for finding out potential risk factors of suicide. The proportional hazards assumption of Cox regression modeling was evaluated with the use of Schoenfeld residuals. All statistical analysis was carried out using R software (version 3.5.2, http://www.r-project.org/). All tests were two‐sided, and the significance level was set at P < 0.05.
3. RESULTS
3.1. Patient baseline characteristics
Overall, 171 819 patients with kidney cancer were identified from the SEER database in 1973‐2015, including 109 810 male patients and 62 009 female patients. Of these, 207 patients (0.1%) died of suicide, 69 182 patients (40.3%) died of other causes, and 102 430 patients (59.6%) were alive. Among all patients, 107 623 (62.6%) of them were married, while 56 515 (32.9%) of them were unmarried. Caucasian was the predominant race. A total of 154 139 (89.7%) patients underwent cancer‐directed surgery and 167 176 (97.3%) patients did not receive radiotherapy. For the patients committed suicide, 179 (86.5%) of them were males, and 28 (13.5%) of them were females. Concerning marital status, 110 (53.1%) of them were married, whereas 92 (44.4%) of them were unmarried. Similarly, Caucasian was also the predominant race. 189 (91.3%) patients received cancer‐directed surgery, and only 4 (1.9%) patients received radiotherapy. Patient demographics and clinical characteristics were summarized in Table 1.
Table 1.
Baseline characteristics of patients with kidney cancer stratified by suicidal death, nonsuicidal death and alive (1973‐2015)
| Variables |
Overall N (%) |
Suicidal death N (%) |
Nonsuicidal death N (%) |
Alive N (%) |
|---|---|---|---|---|
| Patients | 171 819 | 207 | 69 182 | 102 430 |
| Year of diagnosis | ||||
| 1973‐1982 | 4394 (2.6%) | 11 (5.3%) | 4149 (6.0%) | 234 (0.2%) |
| 1983‐1992 | 8968 (5.2%) | 27 (13.0%) | 7740 (11.2%) | 1201 (1.2%) |
| 1993‐2002 | 30 556 (17.8%) | 45 (21.7%) | 20 113 (29.1%) | 10 398 (10.2%) |
| 2003‐2015 | 127 901 (74.4%) | 124 (59.9%) | 37 180 (53.7%) | 90 597 (88.4%) |
| Sex | ||||
| Male | 109 810 (63.9%) | 179 (86.5%) | 45 886 (66.3%) | 63 745 (62.2%) |
| Female | 62 009 (36.1%) | 28 (13.5%) | 23 296 (33.7%) | 38 685 (37.8%) |
| Age at diagnosis | ||||
| ≤39 | 8027 (4.7%) | 6 (2.9%) | 1359 (2.0%) | 6662 (6.5%) |
| 40‐49 | 21 281 (12.4%) | 32 (15.5%) | 5378 (7.8%) | 15 871 (15.5%) |
| 50‐59 | 41 790 (24.3%) | 51 (24.6%) | 13 692 (19.8%) | 28 047 (27.4%) |
| 60‐69 | 50 656 (29.5%) | 59 (28.5%) | 20 332 (29.4%) | 30 265 (29.5%) |
| 70‐79 | 37 206 (21.7%) | 45 (21.7%) | 19 798 (28.6%) | 17 363 (17.0%) |
| ≥80 | 12 859 (7.5%) | 14 (6.8%) | 8623 (12.5%) | 4222 (4.1%) |
| Marital status | ||||
| Married | 107 623 (62.6%) | 110 (53.1%) | 41 999 (60.7%) | 65 514 (64.0%) |
| Unmarried | 56 515 (32.9%) | 92 (44.4%) | 24 726 (35.7%) | 31 697 (30.9%) |
| Unknown | 7681 (4.5%) | 5 (2.4%) | 2457 (3.6%) | 5219 (5.1%) |
| Race | ||||
| White | 140 915 (82.0%) | 192 (92.8%) | 57 204 (82.7%) | 83 519 (81.5%) |
| Black | 20 107 (11.7%) | 7 (3.4%) | 8294 (12.0%) | 11 806 (11.5%) |
| Other | 9822 (5.7%) | 8 (3.9%) | 3615 (5.2%) | 6199 (6.1%) |
| Unknown | 975 (0.6%) | 0 (0.0%) | 69 (0.1%) | 906 (0.9%) |
| Histologic grade | ||||
| Grade I | 18.372 (10.7%) | 16 (7.7%) | 5758 (8.3%) | 12 598 (12.3%) |
| Grade II | 62 462 (36.4%) | 67 (32.4%) | 16 631 (24.0%) | 45 764 (44.7%) |
| Grade III | 33 431 (19.5%) | 45 (21.7%) | 12 499 (18.1%) | 20 887 (20.4%) |
| Grade IV | 8182 (4.8%) | 12 (5.8%) | 4839 (7.0%) | 3331 (3.3%) |
| Unknown | 49 372 (28.7%) | 67 (32.4%) | 29 455 (42.6%) | 19 850 (19.4%) |
| SEER disease stage | ||||
| Localized | 117 927 (68.6%) | 151 (72.9%) | 33 243 (48.1%) | 84 533 (82.5%) |
| Regional | 28 531 (16.6%) | 33 (15.9%) | 14 661 (21.2%) | 13 837 (13.5%) |
| Distant | 22 697 (13.2%) | 19 (9.2%) | 19 560 (28.3%) | 3118 (3.0%) |
| Unstaged | 2664 (1.6%) | 4 (1.9%) | 1718 (2.5%) | 942 (0.9%) |
| Histologic subtypea | ||||
| cRCC | 86 790 (50.5%) | 83 (40.1%) | 27 253 (39.4%) | 59 454 (58.0%) |
| pRCC | 18 119 (10.5%) | 24 (11.6%) | 4886 (7.1%) | 13 209 (12.9%) |
| chRCC | 7388 (4.3%) | 10 (4.8%) | 1132 (1.6%) | 6246 (6.1%) |
| sRCC | 2172 (1.3%) | 2 (1.0%) | 1734 (2.5%) | 436 (0.4%) |
| cdRCC | 412 (0.2%) | 0 (0.0%) | 292 (0.4%) | 120 (0.1%) |
| Others | 56 938 (33.1%) | 88 (42.5%) | 33 885 (49.0%) | 22 965 (22.4%) |
| Surgery performed | ||||
| Yes | 154 139 (89.7%) | 189 (91.3%) | 54 842 (79.3%) | 99 108 (96.8%) |
| No | 16 904 (9.8%) | 17 (8.2%) | 13 766 (19.9%) | 3121 (3.0%) |
| Unknown | 776 (0.5%) | 1 (0.5%) | 574 (0.8%) | 201 (0.2%) |
| Radiotherapy performed | ||||
| Yes | 4643 (2.7%) | 4 (1.9%) | 3916 (5.7%) | 723 (0.7%) |
| No | 167 176 (97.3%) | 203 (98.1%) | 65 266 (94.3%) | 101 707 (99.3%) |
cRCC, clear renal cell carcinoma; pRCC, papillary renal cell carcinoma; chRCC, chromophobe renal cell carcinoma; sRCC, sarcomatoid renal cell carcinoma; cdRCC, collecting duct renal cell carcinoma.
3.2. Difference in suicide rates and SMRs
From 1973 to 2015, there were 207 suicides among 171 819 patients with kidney cancer observed for 948 272 person‐years, yielding a suicide rate of 21.83 per 100 000 person‐years. The suicide rate of US general population reported by the Centers for Disease Control and Prevention was 11.93 per 100 000 person‐years between 1981 and 2015,23 which was significantly lower than that of the kidney cancer patients in our cohort (P < 0.001). The results showed that higher suicide rates in patients with kidney cancer were associated with male sex (vs female, P < 0.001), unmarried status (vs married, Bonferroni‐corrected P < 0.001), white race (vs black race, Bonferroni‐corrected P = 0.002), and cancer‐directed surgery not performed (vs performed, Bonferroni‐corrected P < 0.001). The result of the chi‐square test for linear trend showed that suicide rates among kidney cancer patients increased with histologic grade (P < 0.001) and disease stage (P < 0.001). Meanwhile, no statistical differences in suicide rates were found with respect to year of diagnosis, age at diagnosis, histologic type, radiotherapy, and time from diagnosis. SMRs were used to compare suicide mortality in the study population to that in the general population. A SMR of 1.83 (95% CI: 1.59‐2.10) was noted between kidney cancer patients and the US general population, with 1.57 (95% CI: 1.35‐1.82) for males, 1.60 (95% CI: 1.06‐2.31) for females, 1.85 (95% CI: 1.60‐2.13) for the white race, 1.14 (95% CI: 0.46‐2.35) for the black race, and 2.19 (95% CI: 0.94‐4.31) for other races. A general decline of suicide rates over time after diagnosis was observed, though a statistical trend was not found (P = 0.064). Significantly increased suicide rates among kidney cancer patients with general population were found in the initial 9 years after cancer diagnosis (0‐3 years SMR: 2.04, 95% CI: 1.64‐2.49; 4‐6 years SMR: 1.76, 95% CI: 1.31‐2.32; 7‐9 years SMR: 1.98, 95% CI: 1.38‐2.75). The suicide rates and SMRs of kidney cancer patients diagnosed in 1973‐2015 and 1981‐2015 were presented in Table 2 and Supplementary Table 1, respectively. The sensitivity analysis exhibited good robustness of SMRs.
Table 2.
Suicide rates and SMRs among patients with kidney cancer by demographic and clinic characteristics (1973‐2015)
| Variables | Suicidal death | Person‐years | Suicide rate per 100 000 person‐years | P | SMRa | 95% CI |
|---|---|---|---|---|---|---|
| Total | 207 | 948 272 | 21.83 | ‐ | 1.83 | 1.59‐2.10 |
| Year of diagnosis | ||||||
| 1973‐1982 | 11 | 41 401 | 26.57 | 0.08 | 2.23 | 1.11‐3.99 |
| 1983‐1992 | 27 | 89 349 | 30.22 | 2.53 | 1.67‐3.69 | |
| 1993‐2002 | 45 | 269 896 | 16.67 | 1.40 | 1.02‐1.87 | |
| 2003‐2015 | 124 | 547 626 | 22.64 | 1.90 | 1.58‐2.26 | |
| Sex | ||||||
| Male | 179 | 591 101 | 30.28 | <0.001 *** | 1.57 | 1.35‐1.82 |
| Female | 28 | 357 171 | 7.84 | 1.60 | 1.06‐2.31 | |
| Age at diagnosis | ||||||
| ≤39 | 6 | 59 155 | 10.14 | 0.224 | 0.85 | 0.31‐1.85 |
| 40‐49 | 32 | 146 966 | 21.77 | 1.83 | 1.25‐2.58 | |
| 50‐59 | 51 | 252 419 | 20.20 | 1.69 | 1.26‐2.23 | |
| 60‐69 | 59 | 268 947 | 21.94 | 1.84 | 1.40‐2.37 | |
| 70‐79 | 45 | 175 964 | 25.57 | 2.14 | 1.56‐2.87 | |
| ≥80 | 14 | 44 821 | 31.24 | 2.62 | 1.43‐4.39 | |
| Marital status | ||||||
| Married | 110 | 627 490 | 17.53 | <0.001 *** | 1.47 | 1.21‐1.77 |
| Unmarried | 92 | 282 904 | 32.52 | 2.73 | 2.20‐3.34 | |
| Unknown | 5 | 37 878 | 13.20 | 1.11 | 0.36‐2.58 | |
| Race | ||||||
| White | 192 | 783 889 | 24.49 | <0.001 *** | 1.85 | 1.60‐2.13 |
| Black | 7 | 107 206 | 6.53 | 1.14 | 0.46‐2.35 | |
| Others | 8 | 52 750 | 15.17 | 2.19 | 0.94‐4.31 | |
| Unknown | 0 | 4427 | 0 | ‐ | ‐ | |
| Histologic grade | ||||||
| Grade I | 16 | 126 328 | 12.67 | 0.001 ** | 1.06 | 0.61‐1.72 |
| Grade II | 67 | 355 237 | 18.86 | 1.58 | 1.23‐2.01 | |
| Grade III | 45 | 149 563 | 30.09 | 2.52 | 1.84‐3.37 | |
| Grade IV | 12 | 24 889 | 48.21 | 4.04 | 2.09‐7.06 | |
| Unknown | 67 | 292 255 | 22.93 | 1.92 | 1.49‐2.44 | |
| SEER disease stage | ||||||
| Localized | 151 | 753 396 | 20.04 | <0.001 *** | 1.68 | 1.42‐1.97 |
| Regional | 33 | 148 040 | 22.29 | 1.87 | 1.29‐2.62 | |
| Distant | 19 | 34 591 | 54.93 | 4.60 | 2.77‐7.19 | |
| Unstaged | 4 | 12 245 | 32.67 | 2.74 | 0.74‐7.01 | |
| Histologic subtypeb | ||||||
| cRCC | 83 | 431 537 | 19.23 | 0.299 | 1.61 | 1.28‐2.00 |
| pRCC | 24 | 87 208 | 27.52 | 2.31 | 1.48‐3.43 | |
| chRCC | 10 | 37 833 | 26.43 | 2.22 | 1.06‐4.07 | |
| sRCC | 2 | 3844 | 52.03 | 4.36 | 0.49‐15.75 | |
| cdRCC | 0 | 1323 | 0 | ‐ | ‐ | |
| Others | 88 | 386 527 | 22.77 | 1.91 | 1.53‐2.35 | |
| Surgery performed | ||||||
| Yes | 189 | 922 663 | 20.48 | <0.001 *** | 1.72 | 1.48‐1.98 |
| No | 17 | 23 950 | 70.98 | 5.95 | 3.46‐9.53 | |
| Unknown | 1 | 1659 | 60.28 | 5.05 | 0.07‐28.11 | |
| Radiotherapy performed | ||||||
| Yes | 4 | 12 921 | 30.96 | 0.684 | 2.59 | 0.70‐6.64 |
| No | 203 | 935 351 | 21.70 | 1.82 | 1.58‐2.09 | |
| Time from diagnosis | ||||||
| 0‐3 years | 93 | 382 855 | 24.29 | 0.308 | 2.04 | 1.64‐2.49 |
| 4‐6 years | 51 | 242 432 | 21.04 | 1.76 | 1.31‐2.32 | |
| 7‐9 years | 35 | 148 130 | 23.63 | 1.98 | 1.38‐2.75 | |
| 10‐12 years | 16 | 83 341 | 19.20 | 1.61 | 0.92‐2.61 | |
| >13 years | 12 | 91 514 | 13.11 | 1.10 | 0.57‐1.92 | |
The P and HR values in the bold are statistically significant.
Compared with the suicide rates of the general US population based on the Centers for Disease Control and Prevention's Web‐based Injury Statistics Query and Reporting System (1981‐2015).
cRCC, clear renal cell carcinoma; pRCC, papillary renal cell carcinoma; chRCC, chromophobe renal cell carcinoma; sRCC, sarcomatoid renal cell carcinoma; cdRCC, collecting duct renal cell carcinoma.
P < 0.01,
P < 0.001.
3.3. Associations of risk factors with suicide
The result of univariable analysis presented that significant associations with high risks of suicide were obtained with respect to diagnosis in 1983‐1992 (vs 2003‐2015, HR: 1.61, 95% CI: 1.03‐2.51, P < 0.001), male sex (vs female sex, HR: 3.84, 95% CI: 2.58‐5.72, P < 0.001), older age at diagnosis (70‐79 vs ≤ 39, HR: 2.39, 95% CI: 1.02‐5.61, P = 0.046; ≥80 vs ≤ 39, HR: 2.83, 95% CI: 1.08‐7.40, P = 0.034), unmarried status (vs married status, HR: 1.83, 95% CI: 1.39‐2.41, P < 0.001), white race (vs black race, HR: 3.76, 95% CI: 1.77‐8.00, P < 0.001), higher histologic grade (grade IV vs grade I, HR: 3.60, 95% CI: 1.70‐7.63, P < 0.001; grade III vs grade I, HR: 2.29, 95% CI: 1.29‐4.05, P = 0.005), later disease stage (distant vs localized, HR: 2.53, 95% CI: 1.55‐4.13, P < 0.001), and cancer‐directed surgery not performed (vs performed, HR: 3.19, 95% CI: 1.92‐5.30, P < 0.001). On multivariable Cox regression, the results showed that diagnosis in early years (1973‐1982 vs 2003‐2015, HR: 2.03, 95% CI: 1.01‐4.11, P = 0.048; 1983‐1992 vs 2003‐2015, HR: 1.99, 95% CI: 1.18‐3.35, P = 0.010) and male sex (vs female sex, HR: 4.43, 95% CI: 2.95‐6.65, P < 0.001) were predictive of suicide. Meanwhile, unmarried status (vs married status, HR: 2.54, 95% CI: 1.91‐3.38, P < 0.001) was a significant risk factor of suicide. In addition, the factors associated with high risks of suicide included non‐black race (white race vs black race, HR: 4.47, 95% CI: 2.09‐9.58, P < 0.001; other races vs black race, HR: 3.01, 95% CI: 1.08‐8.37, P = 0.035), higher histologic grade (grade IV vs grade I, HR: 3.27, 95% CI: 1.50‐7.13, P = 0.003; grade III vs grade I, HR: 2.13, 95% CI: 1.19‐3.81, P = 0.011), and cancer‐directed surgery not performed (vs performed, HR: 2.78, 95% CI: 1.52‐5.11, P < 0.001). Conversely, apparent associations of suicide with age at diagnosis, SEER disease stage, histologic subtype, and radiotherapy were not found. Table 3 presented further details about the predictors of suicide in the entire cohort.
Table 3.
Univariable and multivariable analysis for suicide of kidney cancer patients
| Variables | Univariable analysis | Multivariable analysis | ||
|---|---|---|---|---|
| HR(95% CI) | P | HR(95% CI) | P | |
| Year of diagnosis | ||||
| 2003‐2015 | Reference | Reference | ||
| 1993‐2002 | 0.84 (0.59‐1.19) | 0.325 | 0.92 (0.63‐1.34) | 0.654 |
| 1983‐1992 | 1.61 (1.03‐2.51) | 0.036 * | 1.99 (1.18‐3.35) | 0.010 * |
| 1973‐1982 | 1.50 (0.79‐2.85) | 0.211 | 2.03 (1.01‐4.11) | 0.048 * |
| Sex | ||||
| Female | Reference | Reference | ||
| Male | 3.84 (2.58‐5.72) | <0.001 *** | 4.43 (2.95‐6.65) | <0.001 *** |
| Age at diagnosis | ||||
| ≤39 | Reference | Reference | ||
| 40‐49 | 2.12 (0.89‐5,07) | 0.091 | 2.13 (0.89‐5.11) | 0.089 |
| 50‐59 | 1.94 (0.83‐4.52) | 0.126 | 1.96 (0.84‐4.59) | 0.120 |
| 60‐69 | 2.08 (0.90‐4.82) | 0.089 | 2.13 (0.91‐4.96) | 0.080 |
| 70‐79 | 2.39 (1.02‐5.61) | 0.046 * | 2.25 (0.98‐5.79) | 0.055 |
| ≥80 | 2.83 (1.08‐7.40) | 0.034 * | 2.61 (0.99‐6.87) | 0.052 |
| Marital status | ||||
| Married | Reference | Reference | ||
| Unmarried | 1.83 (1.39‐2.41) | <0.001 *** | 2.54 (1.91‐3.38) | <0.001 *** |
| Unknown | 0.74 (0.30‐1.82) | 0.512 | 0.85 (0.34‐2.09) | 0.720 |
| Race | ||||
| Black | Reference | Reference | ||
| White | 3.76 (1.77‐8.00) | <0.001 *** | 4.47 (2.09‐9.58) | <0.001 *** |
| Others | 2.32 (0.84‐6.40) | 0.104 | 3.01 (1.08‐8.37) | 0.035 * |
| Unknown | — | — | — | — |
| Histologic grade | ||||
| Grade I | Reference | Reference | ||
| Grade II | 1.46 (0.84‐2.52) | 0.177 | 1.43 (0.82‐2.47) | 0.204 |
| Grade III | 2.29 (1.29‐4.05) | 0.005 ** | 2.13 (1.19‐3.81) | 0.011 * |
| Grade IV | 3.60 (1.70‐7.63) | <0.001 *** | 3.27 (1.50‐7.13) | 0.003 ** |
| Unknown | 1.85 (1.07‐3.20) | 0.027 | 1.27 (0.72‐2.24) | 0.401 |
| SEER disease stage | ||||
| Localized | Reference | Reference | ||
| Regional | 1.11 (0.76‐1.61) | 0.602 | 0.87 (0.59‐1.28) | 0.483 |
| Distant | 2.53 (1.55‐4.13) | <0.001 *** | 1.44 (0.81‐2.57) | 0.215 |
| Unstaged | 1.62 (0.60‐4.38) | 0.339 | 1.05 (0.37‐3.02) | 0.924 |
| Histologic typea | ||||
| cRCC | Reference | Reference | ||
| pRCC | 1.41 (0.90‐2.22) | 0.137 | 1.44 (0.91‐2.29) | 0.123 |
| chRCC | 1.36 (0.70‐2.61) | 0.364 | 1.60 (0.83‐3.11) | 0.162 |
| sRCC | 2.50 (0.61‐10.20) | 0.200 | 1.54 (0.36‐6.51) | 0.557 |
| cdRCC | — | — | — | — |
| Others | 1.26 (0.93‐1.70) | 0.144 | 1.18 (0.84‐1.65) | 0.338 |
| Surgery performed | ||||
| Yes | Reference | Reference | ||
| No | 3.19 (1.92‐5.30) | <0.001 *** | 2.78 (1.52‐5.11) | <0.001 *** |
| Unknown | 2.82 (0.40‐20.16) | 0.301 | 2.66 (0.36‐19.77) | 0.340 |
| Radiotherapy performed | ||||
| Yes | Reference | Reference | ||
| No | 0.72 (0.27‐1.94) | 0.518 | 1.09 (0.39‐3.06) | 0.876 |
The P and HR values in the bold are statistically significant.
cRCC, clear renal cell carcinoma; pRCC, papillary renal cell carcinoma; chRCC, chromophobe renal cell carcinoma; sRCC, sarcomatoid renal cell carcinoma; cdRCC, collecting duct renal cell carcinoma.
P < 0.05,
P < 0.01,
P < 0.001.
4. DISCUSSION
Several investigations from different countries reported an increased risk of suicide in the populations with cancer diagnosis.11, 24, 25, 26 Allebeck et al reported an increased suicide rate among cancer patients in Sweden, with an SMR of 1.9 for males and 1.6 for females.24 A study from the Danish Cancer Register revealed that the SMRs of suicide for male and female cancer patients were respectively 1.7 and 1.4 in 1971‐1999.25 The researchers from England and Italy also reported a similar result.26, 27 Based on our study, the results showed the suicide rate of kidney cancer patients was 21.83 per 100 000 person‐years, and SMR was 1.83 (95% CI: 1.59‐2.10), indicating an apparent increased risk of suicide in comparison with the US general population. Diagnosed in early years (1973‐1992), male sex, unmarried status, non‐black race, higher histologic grade, and cancer‐directed surgery not performed were significant predictors of suicide.
In reviewing the results, various demographic characteristics were distinctly associated with suicide risk among patients with kidney cancer. The patients diagnosed in 1973‐1992 were more likely to commit suicide in comparison with those diagnosed in 2003‐2015, and this could be possibly explained by the emergence of a new treatment and the accompanying improvement of life quality. Similarly, patients diagnosis with bladder cancer in earlier years (1973‐1983) were at significantly higher risk of suicide compared with those in recent years (2004‐2010).28 In the present study, the suicide rate of males was 30.28 per 100 000 person‐years, which was 2.9 times higher than that of females. Furthermore, males were more likely than females to commit suicide with an HR of 4.43, which was consistent with the findings in the general population and patients with other types of cancer.22, 28 Though it seemed that male and female cancer patients suffered similar pressure, male patients were more likely to react through self‐directed violence.28, 29, 30 Unmarried status was another significant risk factor of suicide with an HR of 2.54 in comparison with married status. Married patients usually had higher cancer‐specific survival and lower mortality in comparison with unmarried patients,31, 32, 33 which could be ascribed to better health, higher socioeconomic status, more emotional support and social attention of married persons.34, 35, 36 The present study corroborated the finding that race had a significant impact on suicidal death. As was reported by the Centers for Disease Control and Prevention, the black race had the lowest suicide rate among all races in the US.37 Our study showed that the suicide rates of the white race and other races were respectively 2.77 and 1.34 times higher than that of the black race. Furthermore, the black race was proved to be a protective factor of suicide, matching the findings in previous investigations.13, 38 In terms of the black race, this finding might be explained by religious beliefs, family support, and culture of rejecting suicide.39 Some recent publications showed that older age was a predictor of suicide for cancer patients and the common population.11, 40 Interestingly, older breast cancer patients who fare better in terms of functional status than younger patients were less likely to commit suicide.13, 41 In our study, a tendency of increased suicide rate with age was also observed, although without statistical association. As reported in previous studies, suicide risk among cancer patients varied by time after diagnosis, and elevated suicide rates could be found in the initial period after diagnosis.27, 38 Our findings showed significantly increased suicide rates among kidney cancer patients with the general population in the initial 9 years after diagnosis. A statistical trend of decreased suicide rates over time was not found, which might be attributed to relative better prognosis of kidney cancer in comparison with other types of cancer.
Regarding specific clinical variables of kidney cancer, several findings should be noteworthy. It was well known that low histologic grade meant well differentiated of cancer cells, predicting good prognosis and improved health‐related quality of life.42 The patients with higher histologic grade (Grade III and IV) in our study were found to have higher suicide risks than those with lower histologic grade (Grade I). However, this finding was contrary to the previous research by Gaitanidis that earlier disease stage and lower tumor grade were associated with higher risks of committing suicide among breast cancer patients. This conflicting result might be partially attributed to the fact that all the patients with breast cancer enrolled in the study had passed away.13
Increased suicide risks were commonly associated with cancer types of poor prognosis.27 Recently, some investigations had reported that histologic subtype was not significantly associated with suicide risks among non‐small cell lung cancer patients and colorectal cancer patients.38, 43 As we know, histologic subtype was a prognostic indicator for kidney cancer survival.19 Compared with clear cell renal cell carcinoma, patients with sarcomatoid renal cell carcinoma and collecting duct renal cell carcinoma had worse overall survival and cancer‐specific survival.44, 45 Conversely, patients with chromophobe histology had improved survival.45 Based on our study, there was no significant difference in suicide rates among patients with different histologic subtypes, and no apparent association between histologic subtype and suicide was found by Cox regression modeling. However, it should be noted that the lack of suicide event for sarcomatoid and collecting duct renal cell carcinoma which was low incidence and poor prognosis might have an effect on this result.
As shown in Table 3, another factor associated with suicide was cancer‐directed surgery. The patients underwent surgery were less likely to commit suicide than those who did not undergo surgery. Samawi et al identified the predictors of suicide in colorectal cancer patients based on the SEER database. Primary site surgery as an independent protective factor was reported in this study, probably attributing to the improvement of mortality after primary tumor resected.14, 46, 47 Similarly, it was reported that patients with cancers of the digestive system who underwent surgery were less likely to commit suicide.48 Conversely, cancer‐directed surgery was associated with increased suicide rate in breast cancer patients, which might be related to the increased adverse psychological impact after mastectomy and the relative body image disturbance.13, 49, 50 Zhou et al reported that cancer‐directed surgery was a risk factor for committing suicide among patients with non‐small cell lung cancer, probably due to the increased frailty and lack of dignity in the postoperative period.38 Jayakrishnan and colleagues investigated the association between suicide and surgery. The patients with cancer who underwent high‐morbidity surgeries (30‐day overall postoperative morbidity > 30%) were more likely to commit suicide than those with low‐morbidity surgeries performed. In addition, no clear association of suicide with the anatomic site of cancer was obtained.40 Indeed, the patients usually suffered from general debility, and experienced depression, hopeless, and despair after surgery, which were risk factors of suicide.40 However, there was no consensus regarding the association between cancer‐directed surgery and suicide so far. Of note, suicide was a complicated phenomenon involving not only physiological but also psychological and social factors. Therefore, more factors should be taken into account to clarify this relationship.
Suicidal behavior in patients with cancer is affected by various factors. Compared with other causes of death such as accident, suicide is preventable.1 It is different to predict suicide, and therefore, more efforts should be made to improve the situation. Based on our findings, we suggest that kidney cancer patients with high risks of suicide should be considered for psychiatric evaluation. At present, several validated tools can be used for identifying depression risk, including the Beck Depression Inventory and the National Comprehensive Cancer Network guidelines.13, 28 Second, the patients at risk should receive psychotherapeutic interventions as soon as possible. It has been widely proved that psychotherapeutic interventions to the depression population can reap benefits in terms of reducing the suicide rate and improving the quality of life, such as participation in cancer support groups, stress management, and integrate psychological support into cancer care.13, 27 Additionally, the efforts for decreasing suicide need coordination and collaboration, including medical workers, family members even the whole society. Besides professional care, family communication and social support also play an important role in preventing suicides and suicide attempts.1, 51, 52
There were some limitations in our study. Besides pathological factors, suicide was affected by psychological and social factors which could not be provided by the SEER database. Moreover, there was also a lack of sufficient medical information in the SEER database, such as pharmacotherapy and genetic factors. Additionally, our study was based on the SEER database, which only collected the corresponding data of cancer patients in the US. Therefore, further study coving more countries should be conducted. Finally, data of failed suicide could not be obtained and exhibited, which might result in an under evaluation to suicide risk.
5. CONCLUSIONS
In summary, our study identified the independent risk factors of suicide for patients with kidney cancer. Diagnosis in early years (1973‐1992), male sex, unmarried status, non‐black race, higher histologic grade, and cancer‐directed surgery not performed were significantly associated with high risks of suicide. Whereas, age at diagnosis. SEER disease stage and radiotherapy did not relate to suicide. Thus, based on our study, clinicians could better screen and perform interventions to those with high risks of suicide, especially at vulnerable stages throughout diagnosis, treatment, and follow‐up. Further investigations are still needed.
CONFLICT OF INTEREST
The authors declare that they have no conflict of interest.
Supporting information
ACKNOWLEDGMENTS
The authors acknowledge the SEER program for providing high quality data to researchers. The authors would like to thank their colleagues from the department of pharmacy for their support to this study.
Guo C, Zheng W, Zhu W, et al. Risk factors associated with suicide among kidney cancer patients: A Surveillance, Epidemiology, and End Results analysis. Cancer Med. 2019;8:5386–5396. 10.1002/cam4.2400
Chenyu Guo and Wenwen Zheng should be considered as joint first author.
DATA AVAILABILITY STATEMENT
The data analysed during the current study are available from the corresponding author on reasonable request.
REFERENCES
- 1. World Health Organization . Preventing suicide: a global imperative. 2014.
- 2. Naghavi M. Global, regional, and national burden of suicide mortality 1990 to 2016: systematic analysis for the Global Burden of Disease Study 2016. BMJ. 2019;364:l94 10.1136/bmj.l94. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. World Health Organization . World health statistics 2018: monitoring health for the SDGs, sustainable development goals. 2018.
- 4. Bostwick JM, Pankratz VS. Affective disorders and suicide risk: a reexamination. Am J Psychiatry. 2000;157(12):1925‐1932. [DOI] [PubMed] [Google Scholar]
- 5. Inskip HM, Harris EC, Barraclough B. Lifetime risk of suicide for affective disorder, alcoholism and schizophrenia. Br J Psychiatry. 1998;172:35‐37. [DOI] [PubMed] [Google Scholar]
- 6. Spijker J, de Graaf R, Ten Have M, Nolen WA, Speckens A. Predictors of suicidality in depressive spectrum disorders in the general population: results of the Netherlands Mental Health Survey and Incidence Study. Soc Psychiatry Psychiatr Epidemiol. 2010;45(5):513‐521. [DOI] [PubMed] [Google Scholar]
- 7. Breitbart W, Rosenfeld B, Pessin H, et al. Depression, hopelessness, and desire for hastened death in terminally ill patients with cancer. JAMA. 2000;284(22):2907‐2911. [DOI] [PubMed] [Google Scholar]
- 8. Ravi P, Karakiewicz PI, Roghmann F, et al. Mental health outcomes in elderly men with prostate cancer. Urol Oncol. 2014;32(8):1333‐1340. [DOI] [PubMed] [Google Scholar]
- 9. Walker J, Waters RA, Murray G, et al. Better off dead: suicidal thoughts in cancer patients. J Clin Oncol. 2008;26(29):4725‐4730. [DOI] [PubMed] [Google Scholar]
- 10. Allebeck P, Bolund C. Suicides and suicide attempts in cancer patients. Psychol Med. 1991;21(4):979‐984. [DOI] [PubMed] [Google Scholar]
- 11. Misono S, Weiss NS, Fann JR, Redman M, Yueh B. Incidence of suicide in persons with cancer. J Clin Oncol. 2008;26(29):4731‐4738. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Zaorsky NG, Zhang Y, Tuanquin L, Bluethmann SM, Park HS, Chinchilli VM. Suicide among cancer patients. Nat Commun. 2019;10(1):207. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Gaitanidis A, Alevizakos M, Pitiakoudis M, Wiggins D. Trends in incidence and associated risk factors of suicide mortality among breast cancer patients. Psychooncology. 2018;27(5):1450‐1456. [DOI] [PubMed] [Google Scholar]
- 14. Samawi HH, Shaheen AA, Tang PA, Heng D, Cheung WY, Vickers MM. Risk and predictors of suicide in colorectal cancer patients: a surveillance, epidemiology, and end results analysis. Curr Oncol. 2017;24(6):e513‐e517. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Turaga KK, Malafa MP, Jacobsen PB, Schell MJ, Sarr MG. Suicide in patients with pancreatic cancer. Cancer. 2011;117(3):642‐647. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Rini BI, Rathmell WK, Godley P. Renal cell carcinoma. Curr Opin Oncol. 2008;20(3):300‐306. [DOI] [PubMed] [Google Scholar]
- 17. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7‐30. [DOI] [PubMed] [Google Scholar]
- 18. Klaassen Z, Jen RP, DiBianco JM, et al. Factors associated with suicide in patients with genitourinary malignancies. Cancer. 2015;121(11):1864‐1872. [DOI] [PubMed] [Google Scholar]
- 19. Steffens S, Janssen M, Roos FC, et al. Incidence and long‐term prognosis of papillary compared to clear cell renal cell carcinoma‐a multicentre study. Eur J Cancer. 2012;48(15):2347‐2352. [DOI] [PubMed] [Google Scholar]
- 20. Tilki D, Nguyen HG, Dall'Era MA, et al. Impact of histologic subtype on cancer‐specific survival in patients with renal cell carcinoma and tumor thrombus. Eur Urol. 2014;66(3):577‐583. [DOI] [PubMed] [Google Scholar]
- 21. Hankey BF, Ries LA, Edwards BK. The surveillance, epidemiology, and end results program: a national resource. Cancer Epidemiol Biomarkers Prev. 1999;8(12):1117‐1121. [PubMed] [Google Scholar]
- 22. Breslow NE, Day NE. Statistical methods in cancer research: volume II‐the design and analysis of cohort studies. New York, NY: Oxford University Press; 1987. [PubMed] [Google Scholar]
- 23. Centers for Disease Control and Prevention . Injury statistics query and reporting system. https://www.cdc.gov/injury/wisqars/fatal.html.
- 24. Allebeck P, Bolund C, Ringback G. Increased suicide rate in cancer patients: a cohort study based on the Swedish Cancer‐Environment Register. J Clin Epidemiol. 1989;42(7):611‐616. [DOI] [PubMed] [Google Scholar]
- 25. Yousaf U, Christensen ML, Engholm G, Storm HH. Suicides among Danish cancer patients 1971–1999. Br J Cancer. 2005;92(6):995‐1000. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26. Innos K, Rahu K, Rahu M, Baburin A. Suicides among cancer patients in Estonia: a population‐based study. Eur J Cancer. 2003;39(15):2223‐2228. [DOI] [PubMed] [Google Scholar]
- 27. Henson KE, Brock R, Charnock J, Wickramasinghe B, Will O, Pitman A. Risk of suicide after cancer diagnosis in England. JAMA Psychiatry. 2019;76(1):51 10.1001/jamapsychiatry.2018.3181. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. Klaassen Z, Goldberg H, Chandrasekar T, et al. Changing trends for suicidal death in patients with bladder cancer: a 40+ year population‐level analysis. Clin Genitourin Cancer. 2018;16(3):206‐212. [DOI] [PubMed] [Google Scholar]
- 29. Hawton K. Sex and suicide: gender differences in suicidal behaviour. Br J Psychiatry. 2000;177:484‐485. [DOI] [PubMed] [Google Scholar]
- 30. Kendal WS. Suicide and cancer: a gender‐comparative study. Ann Oncol. 2007;18(2):381‐387. [DOI] [PubMed] [Google Scholar]
- 31. Niu Q, Lu Y, Wu Y, et al. The effect of marital status on the survival of patients with bladder urothelial carcinoma: a SEER database analysis. Medicine. 2018;97(29):e11378. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32. Wang L, Wilson SE, Stewart DB, Hollenbeak CS. Marital status and colon cancer outcomes in US surveillance, epidemiology and end results registries: does marriage affect cancer survival by gender and stage? Cancer Epidemiol. 2011;35(5):417‐422. [DOI] [PubMed] [Google Scholar]
- 33. Aizer AA, Chen M‐H, McCarthy EP, et al. Marital status and survival in patients with cancer. J Clin Oncol. 2013;31(31):3869‐3876. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34. Wyke S, Ford G. Competing explanations for associations between marital status and health. Soc Sci Med. 1992;34(5):523‐532. [DOI] [PubMed] [Google Scholar]
- 35. Goldzweig G, Andritsch E, Hubert A, et al. Psychological distress among male patients and male spouses: what do oncologists need to know? Ann Oncol. 2010;21(4):877‐883. [DOI] [PubMed] [Google Scholar]
- 36. Woods LM, Rachet B, Coleman MP. Origins of socio‐economic inequalities in cancer survival: a review. Ann Oncol. 2006;17(1):5‐19. [DOI] [PubMed] [Google Scholar]
- 37. Curtin SC, Warner M, Hedegaard H. Suicide rates for females and males by race and ethnicity: United States, 1999 and 2014. NCHS Health E‐Stat. Hyattsville, MD: National Center for Health Statistics; 2016. [Google Scholar]
- 38. Zhou H, Xian W, Zhang Y, et al. Trends in incidence and associated risk factors of suicide mortality in patients with non‐small cell lung cancer. Cancer Med. 2018;7(8):4146‐4155. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39. Neeleman J, Wessely S, Lewis G. Suicide acceptability in African‐ and white Americans: the role of religion. J Nerv Ment Dis. 1998;186(1):12‐16. [DOI] [PubMed] [Google Scholar]
- 40. Jayakrishnan TT, Sekigami Y, Rajeev R, Gamblin TC, Turaga KK. Morbidity of curative cancer surgery and suicide risk. Psychooncology. 2017;26(11):1792‐1798. [DOI] [PubMed] [Google Scholar]
- 41. Kroenke CH, Rosner B, Chen WY, Kawachi I, Colditz GA, Holmes MD. Functional impact of breast cancer by age at diagnosis. J Clin Oncol. 2004;22(10):1849‐1856. [DOI] [PubMed] [Google Scholar]
- 42. Simpson WG, Klaassen Z, Jen RP, Hughes WM, Neal DE, Terris MK. Terris MK. Analysis of suicide risk in patients with penile cancer and review of the literature. Clin Genitourin Cancer. 2018;16(2):e257‐e261. [DOI] [PubMed] [Google Scholar]
- 43. Pham TT, Talukder AM, Walsh NJ et al. Clinical and epidemiological factors associated with suicide in colorectal cancer. Support Care Cancer. 2019;27(2):617‐621. [DOI] [PubMed] [Google Scholar]
- 44. Trudeau V, Larcher A, Sun M, et al. Comparison of oncologic outcomes between sarcomatoid and clear cell renal cell carcinoma. World J Urol. 2016;34(10):1429‐1436. [DOI] [PubMed] [Google Scholar]
- 45. Keegan KA, Schupp CW, Chamie K, Hellenthal NJ, Evans CP, Koppie TM. Histopathology of surgically treated renal cell carcinoma: survival differences by subtype and stage. J Urol. 2012;188(2):391‐397. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46. Clancy C, Burke JP, Barry M, Kalady MF, Calvin CJ. A meta‐analysis to determine the effect of primary tumor resection for stage IV colorectal cancer with unresectable metastases on patient survival. Ann Surg Oncol. 2014;21(12):3900‐3908. [DOI] [PubMed] [Google Scholar]
- 47. Ahmed S, Leis A, Fields A, et al. Survival impact of surgical resection of primary tumor in patients with stage IV colorectal cancer: results from a large population‐based cohort study. Cancer. 2014;120(5):683‐691. [DOI] [PubMed] [Google Scholar]
- 48. Anderson C, Park EM, Rosenstein DL, Nichols HB. Suicide rates among patients with cancers of the digestive system. Psychooncology. 2018;27(9):2274‐2280. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49. Al‐Ghazal SK, Fallowfield L, Blamey RW. Comparison of psychological aspects and patient satisfaction following breast conserving surgery, simple mastectomy and breast reconstruction. Eur J Cancer. 2000;36(15):1938‐1943. [DOI] [PubMed] [Google Scholar]
- 50. Sherman KA, Woon S, French J, Elder E. Body image and psychological distress in nipple‐sparing mastectomy: the roles of self‐compassion and appearance investment. Psychooncology. 2017;26(3):337‐345. [DOI] [PubMed] [Google Scholar]
- 51. Banyasz A, Wells‐Di Gregorio SM. Cancer‐related suicide: a biopsychosocial‐existential approach to risk management. Psychooncology. 2018;27(11):2661‐2664. [DOI] [PubMed] [Google Scholar]
- 52. Kaliampos A, Roussis P. Quality of partner support moderates positive affect in patients with cancer. Psychooncology. 2018;27(4):1298‐1304. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
The data analysed during the current study are available from the corresponding author on reasonable request.